Forbes | In Blowout, Amarin's Fish-Oil-Derived Drug Dramatically Cuts Heart Risk In Study Forbes A drug derived from fish oil cut the rate of cardiovascular problems, including heart attacks and strokes, by 25%, a result that will likely transform the fortunes of its maker, Amarin Pharmaceuticals, and upend decades of thinking about cardiovascular ... |